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Abstract One of the severe combined immunodeficiencies
(SCIDs), which is caused by a genetic defect in the signal
transduction pathways involved in T-cell activation, is the
ZAP70 deficiency. Mutations in ZAP70 lead to both
abnormal thymic development and defective T-cell receptor
(TCR) signaling of peripheral T-cells. In contrast to the
lymphopenia in most SCID patients, ZAP70-deficient
patients have lymphocytosis, despite the selective absence
of CD8+ T-cells. The clinical presentation is usually before
2 years of age with typical findings of SCID. Here, we
present three new ZAP70-deficient patients who vary in
their clinical presentation. One of the ZAP70-deficient
patients presented as a classical SCID, the second patient
presented as a healthy looking wheezy infant, whereas the
third patient came to clinical attention for the eczematous
skin lesions simulating atopic dermatitis with eosinophilia
and elevated immunoglobulin E (IgE), similar to the
Omenn syndrome. This study illustrates that awareness of
the clinical heterogeneity of ZAP70 deficiency is of utmost
importance for making a fast and accurate diagnosis, which
will contribute to the improvement of the adequate
treatment of this severe immunodeficiency.
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Abbreviations
SCID Severe combined immunodeficiency
TCR T-cell receptor
ZAP70 ζ-chain-associated protein kinase of 70 kDa
Ig Immunoglobulin
HSCT Hematopoietic stem cell transplantation
Introduction
Severe combined immunodeficiency (SCID) is a primary
immunodeficiency that is characterized by severely reduced
numbers or the total absence of functional T-cells, which, in
turn, results in the absence of an adaptive immune
response, including strongly reduced or virtually absent
serum immunoglobulin (Ig) levels [4]. Despite the presence
of various underlying genetic defects, patients usually have
a common clinical picture with opportunistic infections,
leading to failure to thrive. The overall incidence is
estimated to be 1 in 50,000 to 75,000 births. Infants with
SCID can be lymphopenic, which aids the early diagnosis
[2, 3]. Defects in any one of the 23 genes inherited either in
an autosomal recessive or an X-linked manner can cause a
combined T- and B-cell immunodeficiency with a well-
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defined immunophenotypical and clinical picture [10, 18].
The various forms of SCID can be classified according to
their lymphocyte phenotype, depending on the presence or
absence of T-, B-, or NK cells, namely, T-B+NK-, T-B+NK+,
T-B-NK+, and T-B-NK- SCIDs [3]. Among T-B+NK+
SCIDs, IL7Rα deficiency and deficiencies in the CD3γ,
CD3δ, CDɛ, or CD3ζ are the known genetic defects [9].
Genetic defects giving rise to the absence of specific T-cell
subsets can be due to a defect in the signal transduction
pathways involved in T-cell activation. This may result,
clinically and immunophenotypically, in heterogeneous
presentations, reflecting highly variable defects ranging
from severe cellular dysfunction to negligible dysfunction.
Defects can involve MHC class I and class II, Lck, ZAP70
(ζ-chain-associated protein kinase of 70 kDa), and CD8α
molecules [1, 5, 11, 13]. Following antigen binding to the
T-cell receptor (TCR) complex, signals are propagated to
the nucleus via nonreceptor cytoplasmic protein tyrosine
kinases (PTKs), namely, Lck and ZAP70 (Fig. 1) [16].
SCIDs resulting from ZAP70 deficiency was first described
in 1994, and is characterized by lymphocytosis, the
selective absence of CD8+ T-cells in peripheral blood, and
profoundly defective signal transduction through the TCR-
CD3 complex on the remaining CD4+ T-cells [7]. To date,
15 cases of ZAP70 deficiency have been reported [1, 7, 14,
15, 19]. The patients usually present before 2 years of age
with a history of recurrent bacterial, viral and opportunistic
infections, diarrhea, and failure to thrive, thereby, meeting
the criteria for the diagnosis of SCID [7]. Here, we present
three cases of ZAP70 deficiency that illustrate the striking
heterogeneity in the clinical presentation of the disease.
Materials and methods
Flow cytometric immunophenotyping
The cell surface expression of CD3, CD4, and CD8 was
assayed on whole-blood samples by flow cytometry using a
FACSCalibur (BD Biosciences, San Jose, CA). Patient
material was obtained according to the medical ethics
guidelines of Hacettepe University Children’s Hospital, the
Meram Medical Faculty of the Selçuk University, and
Erasmus MC. Antibodies were obtained from BD Bioscien-
ces. ZAP70 surface expression was determined using the
monoclonal antibody 1E7.2 (eBioscience, San Diego, CA).
Molecular analysis of the ZAP70 gene
Polymerase chain reaction (PCR) was performed to amplify
the ZAP70 exons (MIM 176947; NCBI L05148); the
primer sequences are available upon request. In each
25 μl of PCR reaction, 5 pmol of 5′ and 3′ oligonucleotides,
25 ng DNA, and 0.5 u AmpliTaqGold™ polymerase
template and buffer PCR System (Applied Biosystems,
Roche Molecular Systems Inc., Branchburg, NJ) were used.
PCR products were used directly for sequencing with
BigDye Terminator mix (Applied Biosystems) and 3.3 pmol
5′ or 3′ primers. All sequencing was performed on an ABI
Prism 3100 fluorescent sequencer (Applied Biosystems).
Ca2+ flux assay
Thawed peripheral blood mononuclear cells (1×106) were
incubated with 6 μg/ml of calcium-sensitive fluorescent dye
Indo-1 (Molecular Probes) to evaluate the calcium fluxes
after stimulation. The levels of free intracellular calcium
were measured in CD4+ T-cells with a FACSVantage sorter
(BD Biosciences) before and after stimulation with 12.5 μg/ml
of functional-grade purified OKT3 CD3 antibody (eBio-
science). Subsequently, 2 μg/ml of ionomycin (Molecular
Probes) was added to control for the intracellular loading of
Indo-1, as previously described [21].
Case reports
Patient 1
The first patient (ZAP70–1) was admitted to the hospital at
the age of 5 months suffering from lower respiratory tract
infection with significant respiratory distress. She experi-
enced recurrent lower respiratory tract infections, usually
without fever, but with accompanying wheezing beginning at
4 months of age. She did not have recurrent oral candidiasis
nor any sign of failure to thrive. Instead, on admission, she
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Fig. 1 Schematic representation of T-cell receptor (TCR) signaling
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was a well-developed baby with a weight and height at the
90th percentile. She had visible tonsils and palpable lymph
nodes. In Fig. 2, the family tree of the case is depicted.
Chest X-ray showed hyperinflation with interstitial
infiltration suggestive for a viral infection. Bronchoalveolar
lavage fluid examination excluded Pneumocystis jiroveci,
cytomegalovirus (CMV), Mycoplasma pneumoniae, and
Mycobacterium species. As shown in Table 1, the immu-
nological findings were suggestive for a combined immu-
nodeficiency (CID), and the low CD8+ T-cell count and the
normal response to phorbol myristate acetate (PMA) and
ionomycin was consistent with a ZAP70 defect.
Patient 2
Patient 2 (ZAP70–2) had experienced recurrent gastroen-
teritis, lower respiratory tract infections, and oral moniliasis
accompanied by failure to thrive, frequently requiring
hospitalization since 3 months of age (Table 1).
On admission at the age of 13 months, both her weight
and height were below the third percentile. She had visible
tonsils and palpable lymph nodes. A scar tissue on the left
deltoid formed following a BCG vaccination was visible.
There were multiple ulcerative perianal and genital lesions.
Her family tree is shown in Fig. 2.
Bone marrow aspiration performed during follow-up
because of the development of hepatomegaly and bicyto-
penia showed hemophagocytosis. Viral serology, PCR
studies, and bacterial cultures could not define an
etiologic agent. The patient was considered to have
secondary hemophagocytic syndrome and was put on
immunosuppressive therapy. The CD8+ T-cell count was
strongly reduced (Table 1). The patient’s clinical status
deteriorated progressively and she died of multiorgan
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Fig. 2 Family trees of the three
patients showing the consan-
guinity of the parents
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failure one month before HLA haploidentical transplanta-
tion could be done.
Patient 3
Patient 3 (ZAP70–3) had experienced recurrent pneumonia
and oral moniliasis since 2 months of age. At 6 months of
age, she developed widespread exfoliative dermatitis and
subcutaneous nodules (Fig. 3).
Physical examination on admission at 11 months of age
showed that her weight, height, and head circumference
were below the third percentile. She had widespread xerosis
and ichthyosis, together with subcutaneous nodules. No
tonsillary tissue was visible. There were bilateral fine rales
on auscultation of the lungs and she had hepatomegaly and
generalized lymphadenopathies of 1–2 cm in size. Com-
puted tomography of the thorax revealed the absence of
thymus, pneumonic consolidation of the right upper lobe,
and a lymphadenopathy located in the azygoesophageal
recess. In Fig. 2, her family tree is shown. The laboratory
findings are shown in Table 1. Additionally, chimerism
analysis ruled out the presence of maternal cells.
With the diagnosis of SCID, the patient was put on
intravenous immunoglobulin (IVIG), antibacterial, antifun-
Table 1 Clinical characteristics and immunological parameters of the three patients with ZAP70 deficiency from unrelated families of Turkish
origin
Patient 1 Patient 2 Patient 3
Age of onset
(months)
4 3 2
Age of diagnosis
(months)
5 13 11
Consanguinity First degree Second degree Second degree
Family history A 3-month-old male
sibling died of LRTI
Insignificant A 2-month-old female cousin
died of unknown reason
Clinical picture Recurrent LRTI (wheezing) Recurrent LRTI Recurrent LRTI
Tonsillary tissue (+) Recurrent gastroenteritis Oral moniliasis
Oral moniliasis Disseminated BCG infection
Perianal and perineal ulcers Generalized lymphadenopathies
Tonsillary tissue (+) Tonsillary tissue (−)
Bilateral inguinal lymphadenopathy
ALC (×109/L) 5.3 2.8 17.1
CD3%/# (×109/L) 78.9/4.2 59.6/1.7 45.7/7.8
CD4%/# (×109/L) 76.3/4 58.5/1.7 37.4/6.4
CD8%/# (×109/L) 1/0.05 0.8/0.02 1.2/0.2
IgA (mg/dl) 118 23 86
IgM (mg/dl) 49 179 72
IgG (mg/dl) 203 785 560
Isohemagglutinin titers Anti B 1/8 (+) Anti A (−), Anti B (−) Anti A 1/4
Blood groups A 0 B
Anti Hbs 60 μ/l (−) (after 2nd dose) (+)
Anti polio titers PT1 (−)* Not tested Not tested
PT2 (−)
PT3 (−)
In vitro lymphocyte
proliferation
test/ (SI)**
PHA: 28.4/85.8 PHA: 22.2/57.9 PHA: 23%
ConA: 4.3/38.4 ConA: 10.6/73.5 Anti CD3: 10%
PMA+I: 35.8/15.9 PMA+I: 49/26
Clinical outcome Well with IVIG and
prophylactic antibiotics,
HSCT has not been
performed yet
Died of multiorgan failure
due to secondary
hemophagocytic syndrome
developed during follow-up
Still under antituberculous
therapy with clinical
improvement, waiting
for HSCT
*Undetectable
**Patient and control values
SI=stimulation index; PMA+I=phorbol myristate acetate+ionomycin; HSCT=hematopoietic stem cell transplantation; LRTI=lower respiratory
tract infection; PT=polio titer; IVIG=intravenous immunoglobulin
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gal, and antiprotozoal prophylaxis. During follow-up,
splenomegaly and several new subcutaneous nodules
developed located on the tibia, gluteal region, anterior chest
wall, and the arm, including the left deltoid region where the
BCG vaccine scar was located. Two separate biopsy speci-
mens obtained from two of the nodules revealed granuloma-
tous inflammation without caseification. No acid-resistant
basil (ARB) was visible and the cultures were negative for
Mycobacterium species. Since both the nodules and spleno-
megaly regressed by a multidrug regimen (isoniazide
+rifampisin+pyrazinamide+streptomycin), she was consid-
ered to have mycobacteria (probably BCG) infection. She
developed generalized erythrodermia with associative eosin-
ophilia and an elevation in IgE levels presenting as Omenn
phenotype. The patient is currently being prepared for an
HLA identical hematopoietic stem cell transplantation
(HSCT) from one of the siblings.
Results
Flow cytometric analysis of the peripheral blood
Flow cytometric analysis of the peripheral blood was
performed for all three patients. Patients 1 and 2 had
normal lymphocyte counts, but patient 3 had lymphocyto-
sis. However, there was a severe reduction in the absolute
number of CD8+ T-cells and almost all CD3+ T-lympho-
cytes were CD4-positive. CD8+ T-cells were found to be
1% (0.05×109), 0.8% (0.02×109), and 1.2% (0.2×109) in
patients 1, 2, and 3, respectively. This phenotypical finding
led us to evaluate the expression of ZAP70 protein in T-
lymphocytes. All three patients did not have ZAP70 protein
expression on their remaining CD4+ T-lymphocytes and
further evaluation of the parents of patients 1 and 2
revealed an intermediate ZAP70 expression as compared
to healthy control cells (Fig. 4).
Molecular analysis of the ZAP70 gene
Direct fluorescent sequencing of the ZAP70 gene of all
three patients revealed homozygous mutations in the
ZAP70 gene (Fig. 5). Patient 1 had a homozygous point
mutation (c.1520C>T), resulting in an amino acid replace-
ment (p.Ala507Val) in the tyrosine kinase domain. The
parents were both carriers of the mutation. In patient 2, the
identified homozygous mutation (c.1010T>G) resulted in
an amino acid substitution (p.Leu337Arg), which is the
amino acid preceding the tyrosine kinase domain. The
mutation in patient 3 concerned a homozygous mutation
(c.1690T>C), also affecting the tyrosine kinase domain (p.
Cys564Arg). The mutation identified in patient 1 has been
described before [21], whereas the other two mutations
concern new mutations.
Calcium flux study
To assess directly the signaling competence of CD4+ cells,
we measured the mobilization of intracellular Ca2+ in the
thawed PBMC of patients 1 and 3. OKT3 antibody was
used to stimulate the classical TCR signaling pathway,
leading to the intracellular mobilization of Ca2+. This
antibody induces TCR cross-linking, but failed to mobilize
significant amounts of intracellular Ca2+ from any of the
patient’s T-cells, whereas biochemical stimulation with
ionomycin could elaborate Ca2+ flux in all of the patient
cells (data not shown).
Discussion
Here, we present three patients from unrelated families with
severe reduction in CD8+ T-cells and the presence of
normal counts of nonfunctional CD4+ T-cells. These cells
are defective in TCR activation, as demonstrated both by
the absence of proliferative response to mitogens and
impaired Ca2+ flux to CD3 (OKT3) stimulation. All three
patients had missense mutations in the ZAP70 gene, leading
to the absence of protein expression.
Although all three mutations lead to the total absence of
ZAP70 protein expression, the clinical pictures of the
patients showed a striking heterogeneity, discarding a
straightforward genotype–phenotype relationship. The age
of onset of the disease of the three patients was before six
months of age, which is quite typical for SCID. In the
literature, the age of onset is variable, however, being
always before 12 months of age. Patients 2 and 3 had a
quite severe phenotypes not compatible with life and
Fig. 3 Patient 3 presented with a marked failure to thrive, exfoliative
dermatitis, and subcutaneous nodules (indicated by the arrows)
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typical for classical SCID and necessitated HSCT for
survival. In contrast, patient 1 had a very mild clinical
phenotype with recurrent attacks of self-limiting lower
respiratory tract infections without failure to thrive. In the
literature, only one patient has been reported as looking
healthy with eczematous skin lesions and without any other
associating symptoms [21].
Patient 3 had generalized progressive erythematous skin
findings associated with eosinophilia and the elevation of
IgE. The patient developed the clinical picture of Omenn
syndrome. The patient’s T-cells were autologous, so not of
maternal origin. Katamura et al. reported two similar cases
who had CD4+ T-cells infiltrating the skin, which were
activated and had a memory phenotype [12]. These cells
proliferated in vitro to a higher concentration of PHA and
seemed to have elevated Syk expression levels. They
suggested that Syk can compensate for ZAP70 during early
T-cell development from double-positive (CD4+CD8+)
thymocytes to single-positive (CD4+ or CD8+) thymocytes.
This was apparently sufficient for reaching the threshold
that leads to the CD4 but not to the CD8 lineage selection,
but was insufficient for eliminating self-reactive T-cells,
which later infiltrated the skin. A second explanation for
skin changes in ZAP70-deficient patients came from
Toyabe et al., who found that T-cells in these patients had
the capacity to induce antigen-specific IgE production from
B cells in response to TCR stimulation [20].
The humoral immunity is also variably affected among the
ZAP70 patients, some having severe hypogammaglobuline-
mia requiring IVIG, some having normal levels of immuno-
globulins, as in patient 2, or even hypergammaglobulinemia
[1, 6, 8, 17]. In sporadic cases, specific antibody production
can be preserved [17, 19]. Only in patient 1 was the protein
antigen response selectively preserved for hepatitis B,
whereas this was not the case in the two other patients.
In conclusion, this study illustrates the clinical hetero-
geneity of patients with a ZAP70 deficiency. These patients
can present as classical SCID, but, sometimes, they present
as healthy looking wheezy infants or can come to clinical
attention for the eczematous skin lesions simulating atopic
dermatitis with eosinophilia and elevated IgE similar to the
Omenn syndrome. Awareness of the clinical heterogeneity
of ZAP70 deficiency is of utmost importance for making a
fast and accurate diagnosis, which will contribute to the
improvement of the adequate treatment of this severe
immunodeficiency.
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